Pei Ling Chia

ABOUT
Pei Ling received her PhD in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai, USA and her BSc in Biochemistry & Molecular Biology from Brown University, USA. She is currently a research fellow at the Institute of Molecular and Cell Biology and a freelance science writer.
Stories by Pei Ling Chia
Accelerating HPC Industry Innovation
High Performance Supercomputing is supercharging industry advancements that impact our daily lives, from making our cities smarter to improving disease diagnosis.
An Eye On AI
Backed by immense computing power, breakthroughs in AI are transforming multiple facets of society, from the way we deliver patient care to how we harness renewable energy resources like solar power.
Five Ways HPC Is Enabling Digital-Based Learning
New interactive and immersive learning methods are entering the education landscape. With high-performance computing at the forefront, education across Asia is experiencing a digital transformation.
This New Antibody Drug Could Slow Down Cancer
PRL3-zumab, an antibody drug targeting a protein in cancer cells, has shown safety and efficacy in clinical trials.
Accelerating HPC Industry Innovation
High Performance Supercomputing is supercharging industry advancements that impact our daily lives, from making our cities smarter to improving disease diagnosis.
An Eye On AI
Backed by immense computing power, breakthroughs in AI are transforming multiple facets of society, from the way we deliver patient care to how we harness renewable energy resources like solar power.
Five Ways HPC Is Enabling Digital-Based Learning
New interactive and immersive learning methods are entering the education landscape. With high-performance computing at the forefront, education across Asia is experiencing a digital transformation.
This New Antibody Drug Could Slow Down Cancer
PRL3-zumab, an antibody drug targeting a protein in cancer cells, has shown safety and efficacy in clinical trials.